Incyte announces FDA approval of Zynyz(TM), indicated for the treatment of metastatic or recurrent locally advanced Merkel Cell Carcinoma (MCC) (skincancer )
The active substance is the monoclonalantibody Retifanlimab, expressed using recombinant Chinese Hamster Ovary (CHO).
Once again, the role of CHO cells in the development of new therapies has been essential and their use in research and development to produce and select candidates is intensive.
We, at Magellan Biologics & Consulting support the scientific community by:
👉 expressing our clients’ proteins in CHO 4Tx®, our system for transient protein expression system in CHOs – at small scale (from 10 mL to 1000 mL), ideal for discovery programs
👉 transferring our know-how and delivering our CHO 4Tx® cells + media for our customers to setup or potentiate their own TGE lab in their facility. Indeed, CHO 4Tx® has been shown to increase yield by 2 to 7 fold when compared to the industry standards.
👉 advising and ensuring full technical support to our clients until the best possible solution is found. The quality of our service is widely recognized and often makes the difference.
Keep ahead of your competitors by using today the next Industry Reference: give it a try:
support@magellanbiologics.com
